AI firm Anthropic has launched Project Glasswing, an initiative which uses AI to identify and remediate undiscovered cybersecurity vulnerabilities in critical software. Project Glasswing, named after ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

“What’s fun about the movie is that there is no green screen in the movie whatsoever. Not a single green or blue screen was used,” Miller told ComicBook on the film’s press tour. “The whole ship was ...

Tirzepatide use was associated with a reduced 12-month risk for diabetic retinopathy incidence and worsening events vs lifestyle intervention alone. HealthDay News — For patients with diabetes and ...

Tirzepatide also linked to fewer complications, including those requiring interventions, compared with lifestyle intervention alone. (HealthDay News) — For patients with diabetes and overweight or ...

Diabetic retinopathy remains a leading cause of preventable vision loss, yet predicting which patients will experience disease progression remains challenging. This study demonstrates that subtle ...

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...

Feb 10 (Reuters) - U.S. pipeline operator Williams Companies (WMB.N), opens new tab on Tuesday forecast 2026 profit above analysts' expectations as new pipeline and offshore projects drive growth and ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

BioMed X, a Heidelberg, Germany-based innovation hub for pharma, launched its first research project in partnership with the Government of Barbados and with support from the European Union’s ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min St. John Properties is breaking ...